These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12358849)

  • 21. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA matching at the epitope level: the way to go.
    Duquesnoy RJ
    Clin Transpl; 2013; ():441-51. PubMed ID: 25095540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: Antigenic, allelic, epitope, or physiochemical HLA mismatches?
    Delion A; Girerd S; Duarte K; Girerd N; Schikowski J; Kessler M; Frimat L; Aarnink A
    Clin Transplant; 2019 Apr; 33(4):e13508. PubMed ID: 30821002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should epitope-based HLA compatibility be used in the kidney allocation system?
    Duquesnoy RJ
    Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ABCs (DRDQDPs) of the prozone effect in single antigen bead HLA antibody testing: Lessons from our highly sensitized patients.
    Greenshields AL; Liwski RS
    Hum Immunol; 2019 Jul; 80(7):478-486. PubMed ID: 31080010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines.
    El-Awar N; Nguyen A; Almeshari K; Alawami M; Alzayer F; Alharbi M; Sasaki N; Terasaki PI
    Hum Immunol; 2013 Sep; 74(9):1141-52. PubMed ID: 23756161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of panel reactive antibodies in patients requiring kidney transplantation.
    Mishra MN; Baliga KV
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):495-9. PubMed ID: 23640620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral sensitization against rejected grafts: specific antibodies to graft immunogenic amino acid triplets.
    Iniotaki-Theodoraki A; Kalogeropoulou E; Apostolaki M; Doxiadis IN; Stavropoulos-Giokas C
    Transplant Proc; 2004; 36(6):1728-31. PubMed ID: 15350463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of acceptable HLA mismatches in highly sensitized patients by soluble HLA class I ELISA inhibition.
    Koelman CA; van Beelen E; Witvliet MD; Doxiadis II; Claas FH
    Transplantation; 2000 Feb; 69(4):656-60. PubMed ID: 10708125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
    Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.
    Filippone EJ; Farber JL
    J Immunol Res; 2016; 2016():5197396. PubMed ID: 28070526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
    Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.